Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Sema4 and BioSymetrics have formed a strategic partnership to accelerate the advancement of new medicines for patients and pharmaceutical companies. The partnership will leverage Centrellis®, Sema4’s...
View this email in your browser Career News – February 22, 2022 Alva Health Full Stack Engineer Full-time, Remote Ancera Senior Development Engineer – Biochemistry...
IsoPlexis reports the publication of a study in which researchers used IsoPlexis’ single-cell functional proteomics platform to identify factors that may predict sustained disease after COVID-19...
“Every adult needs to have their cholesterol checked to determine their baseline risk of heart disease,” recommends Dr. John Glenn Tiu, a preventive cardiologist at UConn...
Even while hammering home the message of vigilance to protect against the spread of COVID-19, medical experts like Dr. Jaime Imitola acknowledge the growing presence...
View this email in your browser Weekly Roundup – February 17, 2022 Yale‘s Office of Cooperative Research (OCR) has a new managing director: Josh Gabelle. In his...
Yale scientists are investigating PDA, a congenital heart defect common in premature infants. “The disease is caused by a defect in a region of brain that is...
Sten H. Vermund, MD, PhD, a pediatrician and infectious disease epidemiologist focused on diseases of low and middle income countries and health disparities in the...
Qx Therapeutics reports that the FDA has cleared the company’s initial Investigational New Drug application (IND) for investigating its lead investigational drug product, QXT-101. The trial protocol is...
Branford-based life science technology company IsoPlexis is expanding in the Asia-Pacific region. The company has opened four service labs in large cities in China, including Shanghai, Beijing,...